Programa de educa����o e prevenção em sa��de bucal nas escolas: an��lise cr��tica de publica����es nacionais

Objective: To conduct a survey on national databases about Oral Health Program (OHP) publications in schools, in the last eleven years. Material and Methods: A survey was conducted in two main bases of national publications in the field of dentistry: Bireme and Scielo. To start the research, it was used the articles theme/subject. In the search, it was used the keywords 'oral health education', 'programs and oral health and dentistry', 'programs and oral health and education'. Results: A total of 20 publications were selected. From these, seven (35%) had the aim to evaluate educational methods used in OHP, 12 (60%) evaluated the effectiveness of the OHP itself developed in the school and one (5%) reported the experience of OHP. Only two publications did not get positive results and the other eighteen obtained advantageous results. Conclusion: In the national scientific literature, there are few publications about the subject in question, suggesting that the successful experiences about OHP in schools must be published to be replicated in other parts of Brazil.

Perfil epidemiol��gico dos participantes do Programa de diagn��stico e prevenção do c��ncer de boca em Mato Grosso

To determine the profile of the patients who participated in the program of oral cancer diagnosis and prevention in Mato Grosso, from 2008 to 2009. Materials and Methods: The medical records of the treated patients were examined. Results: 1.293 records were analyzed, with a predominance of female patients (60%) and a greater participation of patients from 10 to 19 years of age (20%). Reports of pre-existing illnesses amounted to 302 recorded cases. In addition, 292 variations of normality could be also identified. During the period, 25 participants were recommended for exfoliative cytology and 133 for biopsy, as they presented oral lesions that raised the suspicion of malignancy. Conclusions: Campaigns to raise awareness of and prevent oral cancer are very important and should be extended to the entire population of the state of Mato Grosso, either by means of the local University Center (UNIVAG), or by other agencies and health institutions.

Avalia����o do curativo de hidr��xido de c��lcio para a prevenção da infiltra����o coron��ria por um per��odo curto

Objetivo: o objetivo desse estudo in vivo foi avaliar a influ��ncia da infiltra����o coron��ria no reparo apical de dentes de c��es que receberam curativo de demora com hidr��xido de c��lcio e foram mantidos, ou n��o, em contato com o meio bucal. M��todos: ap��s o preparo biomec��nico e preenchimento com pasta de hidr��xido de c��lcio, 26 canais foram divididos aleatoriamente em dois grupos experimentais (Grupo 1 = selamento coron��rio com material restaurador tempor��rio; Grupo 2 = n��o selados). Os animais foram sacrificados ap��s 7 dias e os esp��cimes foram preparados para an��lise histol��gica. Resultados: em ambos os grupos, os resultados foram semelhantes, c��lulas inflamat��rias n��o estavam presentes no tecido apical ou no cemento. Al��m disso, observou-se necrose na superf��cie do ter��o coron��rio do coto pulpar em contato com o hidr��xido de c��lcio, e microrganismos foram observados apenas em contato com res��duos que estavam presentes na c��mara pulpar dos esp��cimes sem selamento, mas n��o no canal radicular. Conclus��o: concluiu-se que o hidr��xido de c��lcio utilizado como curativo impediu a contamina����o do canal radicular e manteve seu mecanismo de a����o nos tecidos apicais, mesmo sem selamento coron��rio, por um per��odo de 7 dias.

Boas pr��ticas de laborat��rio e biosseguran��a: prevenção dos riscos ergon��micos

El control de los riesgos ergon��micos es parte del paquete de medidas de Buenas Pr��cticas de Laboratorio y Bioseguridad. De este modo, la mala postura, la iluminaci��n o ventilaci��n inadecuadas , prolongada jornada de trabajo, la monoton��a y la actividad repetitiva, intensa rutina, el control de la productividad , el estr��s y el trabajo por la noche son factores a los riesgos ergon��micos. Como se relacionan a los elementos f��sicos y de organizaci��n tambi��n pueden interferir con la comodidad y la salud del personal de laboratorio. Riesgos ergon��micos no s��lo pueden generar trastornos psicol��gicos y fisiol��gicos que causan graves da��os a la salud, sino tambi��n comprometer la productividad del laboratorio y reducir el equipo de seguridad , ya que producen cambios en el cuerpo y el estado emocional, tales como trastornos o lesiones relacionadas con el cansancio f��sico producido por el trabajo repetitivo, dolor muscular, alteraciones del sue��o, diabetes, trastornos de los nervios , la taquicardia , las enfermedades del aparato digestivo (gastritis y ��lcera ), tensi��n, ansiedad, problemas de espalda y la hipertensi��n. En este trabajo se propone una secuencia de actividad laboral (gimnasia) en el intervalo de tiempo peque��o, respetando las instalaciones y el espacio f��sico disponible en el ambiente del trabajo, como una estrategia para mejorar la calidad de vida laboral, para aumentar la productividad, mejorar la disposici��n a trabajar y para aumentar el conocimiento del cuerpo y de la interacci��n social.

S��ntese e avalia����o farmacol��gica de pr��-f��rmacos derivados do ��cido micofen��lico ��teis na prevenção e no tratamento da rejei����o de transplantes

P��s-gradua����o em Ci��ncias Farmac��uticas - FCFAR

A����o de vigil��ncia em acidentes do trabalho com o uso Modelo de An��lise e Prevenção de Acidentes (MAPA) em Piracicaba/SP

P��s-gradua����o em Sa��de Coletiva - FMB

Estrat��gias de prevenção e conten����o do bullying nas escolas: as propostas governamentais e de pesquisa no Brasil e na Espanha

Coordena����o de Aperfei��oamento de Pessoal de N��vel Superior (CAPES)

Conhecimento dos enfermeiros sobre as a����es de prevenção da infec����o de corrente sanguinea associada ao cateter venoso central

P��s-gradua����o em Enfermagem (mestrado profissional) - FMB

Recomenda����es para prevenção cl��nica: aspectos relevantes em idosos

The American Academy of Family Physicians (AAFP) released a summary of the ���Recommendations for Clinical Preventive Services���. It is a publication based on ���Recommendations for Clinical Preventive Services��� published by the United States Preventive Services Task Force (USPSTF). These recommendations are provided only as an aid to physicians in making clinical decisions about the care of their patients. They reflect the clinic references existing at the time of publication. But its only should be used with the clear understanding that continued research may result in new knowledge and consequently there is a need for updates. Some recommendations of the USPSTF are important in clinical practice with the elderly.

Prevenção da repeti����o de epis��dos de rea����o tipo 2 da Hansen��ase com o uso da talidomida na dose de 100mg/dia

Introdu����o: A hansen��ase �� doen��a cr��nica que pode ter seu curso interrompido por epis��dios reacionais tipo 1 e 2 ou ENH, sendo que estes podem ser repetitivos, com conseq��entes danos ao paciente.A talidomida �� a medica����o de elei����o para o controle, desde 1965. Objetivo: Evitar repeti����o de epis��dios reacionais. Material e M��todo: Ap��s o controle da rea����o com dose tradicional, utilizou-se 100mg/d, pelo per��odo de seis meses, com acompanhamento por seis meses ap��s a suspens��o. Resultados: Foram avaliados 42 pacientes MB, 39 (92,85%) da forma V e 3(7,15%) da D, que apresentaram ENH, como primeiro epis��dio ou repeti����o, 33(78,6%) do sexo masculino e9(21,4%) do feminino. As idades variaram de 18 a 84 anos, predom��nio acima de 49 anos.N��o se observou repeti����o em 100% dos pacientes durante o uso dessa dose.Durante a observa����o clinica, 33(78,6%)continuaram sem apresentar rea����o e9(21,4%), todos da forma V,a apresentaram, de forma leve,sem sinais e sintomas, controlada com antinflamat��rios n��o hormonais. N��o houve efeitos adversos. Conclus��es: sugere-se o uso da talidomida, 100mg/ dia, como manuten����o, que foi efetiva, impedindo a repeti����o das rea����es tipo 2.

A����es educativas sobre prevenção de acidentes infantis com professoras de educa����o infantil

P��s-gradua����o em Educa����o - FFC

O Tracoma no Munic��pio de Botucatu - Estado de S��o Paulo: medidas de Detec����o, Educa����o em Sa��de, Prevenção e Tratamento

Funda����o de Amparo �� Pesquisa do Estado de S��o Paulo (FAPESP)

Detection of dengue virus in sera of Brazilian blood donors

BACKGROUND: Dengue is the most important arboviral disease in the world. Dengue viruses (DENVs) have produced huge outbreaks in Brazil in the past 25 years with more than 5 million reported cases. During these epidemics, asymptomatic individuals infected with DENV could donate blood and serve as a source of virus dissemination in the community. Here, we studied the circulation of DENV in healthy individuals during an epidemic outbreak. STUDY DESIGN AND METHODS: The study included 500 serum samples from healthy blood donors collected at the Hemotherapy Center of Ribeirao Preto, Brazil, during a dengue outbreak. The presence of DENV RNA in the serum samples was screened by real-time reverse transcriptionpolymerase chain reaction (PCR). The virus serotype was determined by a heminested PCR procedure. A partial fragment of the NS5 gene sequence was used for phylogenetic analysis. RESULTS: DENV RNA was detected in the serum sample of 2 of 500 (0.4%) individuals. Both of them were infected with DENV-3 Genotype III, a virus that has been circulating in Brazil in the past decade. CONCLUSION: Individuals with asymptomatic DENV infection can be blood donors and serve as a source of virus dissemination in the community. Further studies are needed to determine the risk of recipient infection by DENV as a result of transfusion in Brazil, especially during epidemic periods.

Designing a vaccination strategy against dengue

In this work we propose a mathematical approach to estimate the dengue force of infection, the average age of dengue first infection, the optimum age to vaccinate children against dengue in a routine fashion and the optimum age interval to introduce the dengue vaccine in a mass vaccination campaign. The model is based on previously published models for vaccination against other childhood infections, which resulted in actual vaccination programmes in Brazil. The model was applied for three areas of distinct levels of endemicity of the city of Recife in Northeastern State of Pernambuco, Brazil. Our results point to an optimal age to introduce the dengue vaccine in the routine immunization programme at two years of age and an age interval to introduce a mass vaccination between three and 14 years of age.